Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuning Le

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Nature Cell Biology|October 13, 2025
CoCo-ST detects global and local biological structures in spatial transcriptomics datasetsMuhammad Aminu, Bo Zhu, Natalie Vokes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 16, 2025
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology SubcommitteeHongcheng Zhu, Said Al Saifi, Houda Bahig, et al.
Head & Neck|February 1, 2021
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neckSamantha Tam, Mona Gajera, Xiaoning Luo, et al.
JAMA Oncology|June 4, 2023
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical TrialJulien Mazieres, Paul K Paik, Marina C Garassino, et al.
European Radiology|December 17, 2025
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancerXiaoyu Han, Wentao Li, Julie Lin, et al.
Science Translational Medicine|September 4, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint componentsMonique B Nilsson, Huiying Sun, Jacqulyne Robichaux, et al.
Lung Cancer (Auckland, N.Z.)|June 28, 2024
Top 20 <i>EGFR+</i> NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating <i>EGFR</i> Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus SurveySai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2026
Compound EGFR mutations are predominantly PACC (P-loop and alpha-C helix compressing) mutations with increased responsiveness to second- vs third-generation tyrosine kinase inhibitorsXimeng Liu, Moses Stamboulian, Maxime Borgeaud, et al.
Cancers|July 27, 2022
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung AdenocarcinomaLingzhi Hong, Whitney E Lewis, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLCNatalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Nature Cell Biology|October 13, 2025
CoCo-ST detects global and local biological structures in spatial transcriptomics datasetsMuhammad Aminu, Bo Zhu, Natalie Vokes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 16, 2025
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology SubcommitteeHongcheng Zhu, Said Al Saifi, Houda Bahig, et al.
Head & Neck|February 1, 2021
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neckSamantha Tam, Mona Gajera, Xiaoning Luo, et al.
JAMA Oncology|June 4, 2023
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical TrialJulien Mazieres, Paul K Paik, Marina C Garassino, et al.
European Radiology|December 17, 2025
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancerXiaoyu Han, Wentao Li, Julie Lin, et al.
Science Translational Medicine|September 4, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint componentsMonique B Nilsson, Huiying Sun, Jacqulyne Robichaux, et al.
Lung Cancer (Auckland, N.Z.)|June 28, 2024
Top 20 <i>EGFR+</i> NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating <i>EGFR</i> Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus SurveySai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2026
Compound EGFR mutations are predominantly PACC (P-loop and alpha-C helix compressing) mutations with increased responsiveness to second- vs third-generation tyrosine kinase inhibitorsXimeng Liu, Moses Stamboulian, Maxime Borgeaud, et al.
Cancers|July 27, 2022
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung AdenocarcinomaLingzhi Hong, Whitney E Lewis, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLCNatalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Pageof 18